Aspiriant Risk-Managed Equity Allc Adv holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Aspiriant Risk-Managed Equity Allocation Fund Advisor Shares RMEAX
- NAV / 1-Day Return 17.26 / +0.41 %
- Total Assets 1.4B
-
Adj. Expense Ratio
1.240%
- Expense Ratio 0.290%
- Distribution Fee Level High
- Share Class Type No Load
- Category Global Large-Stock Blend
- Investment Style Large Blend
- Min. Initial Investment 0
- Status Open
- TTM Yield 1.44%
- Turnover 21%
USD | NAV as of Jun 13, 2026 | 1-Day Return as of Jun 13, 2026, 12:23 AM GMT+0
Morningstar’s Analysis RMEAX
Will RMEAX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the RMEAX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of RMEAX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 72.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
GMO Quality VI | 33.37 | 428M | — |
Schwab Fundamental Emerging MarketsEqETF | 7.64 | 98M | — |
RIEF STRATEGIC PARTNERS FUND | 7.16 | 92M | — |
Baillie Gifford Emerging Markets Eqs K | 5.01 | 64M | — |
GMO Equity Dislocation Invmt A USD Acc | 4.78 | 61M | — |
AQR Large Cap Defensive Style R6 | 4.04 | 52M | — |
Viking Global Equities Lp | 3.92 | 50M | — |
JPMorgan Prime Money Market Inst | 3.43 | 44M | Cash and Equivalents |
iShares MSCI Global Min Vol Factor ETF | 3.11 | 40M | — |
iShares MSCI ACWI ETF | 2.32 | 30M | — |
United States